November 03, 2020
Robocath Enters Joint Venture With MicroPort to Commercialize Cath Lab Robotic System in China
November 3, 2020 – Robocath, a company commercializing cardiovascular cath lab robotic systems, announced creation of…
Read More
Two of the top preforming pieces of content in October was the FDA clearance for the first indication for shortened DAPT for Medtronic's Resolute Onyx Drug Eluting Stent. A virtual tour of the new robotic electrophysiology lab at Banner Health led by Pete Weiss, M.D., also was among the most popular cardiology technology content.
November 02, 2020
Most Popular Cardiology Technology Content in October 2020
November 2, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
Angiography with a co-registered view of pressure drops according iFR readings in a coronary vessel. The DEFINE PCI study showed patients had improved outcomes and less recurrent chest pain at one year using iFR physiologic measurements combined with landmarks shown on angiographic imaging to better guide therapy. Image by Philips Healthcare. #TCT #TCT2020 #TCTconnect
Dave Fornell, Editor
October 30, 2020
FFR Studies Find Several Surprises at TCT 2020
Fractional flow reserve (FFR) is considered the gold standard measure whether a coronary lesions needs a percutaneous…
Read More
Some of the device technologies discussed in the TCT 2020 late-breaking trial sessions. Top left, the  Medtronic Resolute Onyx stent was the first stent to receive FDA clearance for short duration dual-antiplatelet therapy, which was a big topic and subject of several sessions. Lower left, the Keystone TriGuard 3 TAVR embolic protection device did not demonstrate superiority over TAVR without use of embolic protection. Top right, the Abbott MitraClip. Acurate neo TAVR valve. #TCTconnect #TCT2020
Dave Fornell, Editor
October 29, 2020
Top 10 Takeaways on Interventional Technologies at TCT 2020
Here are some of the key takeaways from the late-breaking interventional cardiology and structural heart trials…
Read More
This study found cardiac MRI gadolinium-based contrast agents are safe for patient use. Overall, there were only 556 acute adverse effects in 145,855 contrast-enhanced MRIs, with only 47 being classified as severe.
October 29, 2020
Cardiac MRI Contrast Agents Carry Low Risk of Adverse Events
October 29, 2020 — Contrast agents used to improve views of the heart on magnetic resonance imaging (MRI) carry a very…
Read More
The Watchman FLX will be tested in the CHAMPION-AF trial looks at next-generation transcatheter LAA device as treatment alternative to NOACs for broader population of patients with non-valvular atrial fibrillation.
October 29, 2020
Boston Scientific Initiates Trial to Evaluate Watchman FLX LAA Closure Device as First-Line Treatment
Oct. 29, 2020 — Boston Scientific initiated the CHAMPION-AF clinical trial to evaluate the safety and efficacy of the…
Read More
A sonographer at Northwestern Memorial Hospital using the Caption Health AI to optimize ultrasound imaging. Northwestern Memorial Hospital in Chicago is the first in U.S. to adopt Caption AI (artificial intelligence) to improve ultrasound imaging in emergency department, ICU and cardio-oncology clinic  
October 28, 2020
Northwestern Medicine Introduces Artificial Intelligence to Improve Ultrasound Imaging
October 28, 2020 — Northwestern Memorial Hospital is the first hospital in the United States to purchase Caption Health…
Read More
The September-October 2020 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine. Dave Fornell is the editor. #DAIC
October 28, 2020
View the DAIC Sept-Oct 2020 Digital Edition
The September-October 2020 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine include links to…
Read More
Chest X-ray, posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.
October 27, 2020
MRI Can Be Safely Performed in Patients With Pacemakers and ICDs
October 27, 2020 – Magnetic resonance imaging (MRI) examinations can be safely performed in patients with non-MR…
Read More
The Abiomed Breethe OXY-1 System has received U.S. FDA 510(k) clearance. 
October 26, 2020
FDA Clears Abiomed Compact ECMO System for COVID-19 and Cardiogenic Shock Patients
October 26, 2020 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed for an all-in-…
Read More
Abre venous self-expanding stent found safe, effective in treating challenging deep venous lesions was approved by the FDA.
October 26, 2020
Medtronic Venous Stent Receives U.S. FDA Approval to Treat Venous Outflow Obstruction
October 26, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic Abre venous self-expanding…
Read More
Patient case example of the FlowTriever thrombectomy device from Inari Medical Inc. in removing a pulmonary embolism and reporting blood flow and clot burden removed by the system. #TCT2020 #TCTconnect
October 23, 2020
Acute Hemodynamic Improvement With Percutaneous Mechanical Thrombectomy in a Real-world Pulmonary Embolism Population
October 23, 2020 —  Positive results were reported on the first 230 patients enrolled in its FLASH study, a real world…
Read More
Fractional Flow reserve (FFR) selection on the Abbott, St. Jude FFR system console. The TARGET FFR study at #TCT2020 #TCTconnect.
October 23, 2020
FFR-guided PCI Optimization Strategy May Lead to Improved Outcomes
October 23, 2020 – Results from the randomized controlled TARGET FFR trial show that while a physiology-guided…
Read More
An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone actually was not flow limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings. #TCT2020 #TCTconnect
Dave Fornell, Editor
October 22, 2020
FFR-CT Did Not Significantly Reduce Costs But Reduced Rates of Invasive Coronary Angiography
October 22, 2020 – In the FORECAST randomized clinical trial, the use of fractional flow reserve (FFR) derived from…
Read More
Ori Ben-Yehuda, M.D., presenting the findings of the HOST-REDUCE-POLYTECH-ACS study at TCT 2020 that showed durable polymer drug-eluting stents (DES) performed better than the bioresorbable polymer DES that were supposed to replace them with the promise of being safer and lowering overall cardiac event rates. #TCT2020 #TCTConnect
Dave Fornell, Editor
October 22, 2020
Durable Polymer Drug-Eluting Stents Perform Better Than Biodegradable Polymer DES
October 17, 2020 – In a surprise to many, a randomized clinical trial found that drug-eluting stents (DES) with durable…
Read More
For patients undergoing percutaneous coronary intervention (PCI), treatment with the CeloNova Biosciences nanotechnology polymer-coated Cobra PzF stent plus 14-day dual anti-platelet therapy (DAPT) did not reduce bleeding or establish non-inferior outcomes for thrombotic events compared with a drug-eluting stent (DES) and standard three or six-month DAPT therapy. #TCT #TCTconnect #TCT2020
October 22, 2020
Nano-Coated Coronary Stent and Shorter DAPT Did Not Meet Non-inferiority for Thrombotic Events
October 22, 2020 – For patients undergoing percutaneous coronary intervention (PCI), treatment with the nanotechnology…
Read More
A large subgroup analysis of the VOYAGER PAD randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. #TCT2020 #TCTconnect
October 18, 2020
No Mortality Risk Associated With Paclitaxel-coated Devices Used to Treat Peripheral Artery Disease
October 18, 2020 – A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benefit…
Read More
The first results from the IN.PACT Below the Knee (BTK) Study, a feasibility study assessing the safety and effectiveness of the Medtronic  IN.PACT 0.014 drug-coated balloon (DCB) in critical limb ischemia (CLI) subjects with chronic total occlusion (CTO) in the infrapopliteal arteries. The data were presented in the Late-Breaking Clinical Trial Sessions at 2020 Transcatheter Cardiovascular Therapeutics (TCT) Connect virtual symposium of the Cardiovascular Research Foundation (CRF). #TCTconnect #TCT2020
October 18, 2020
Drug-coated Balloon for Challenging Below-the-Knee Disease Shows Promise in Patients with Critical Limb Ischemia
October 18, 2020 – The first results from the IN.PACT Below the Knee (BTK) Study, a feasibility study assessing the…
Read More
A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin capped fibrous atheroma (TCFA). #TCTconnect #TCT2020
October 18, 2020
Combined FFR and OCT Imaging Can Improve Accuracy of High-Risk Lesion Identification in Patients With Diabetes
October 18, 2020 – Data from the COMBINE (OCT-FFR) study found that the use of FFR combined with OCT imaging can help…
Read More
Illustration showing how the near-infrared spectroscopy (NIRS) intravascular ultrasound (IVUS), of NIRS-IVUS, intracoronary imaging system can help identify angiographically non-obstructive lesions with high-risk characteristics for future adverse cardiac outcomes. The system can identify unstable, vulnerable plaques. #TCTconnect #TCT2020
October 18, 2020
NIRS-IVUS Imaging Can Help Identify High-Risk Plaques That Can Lead to Adverse Outcomes
October 18, 2020 – New data from the PROSPECT II study shows that near-infrared spectroscopy (NIRS) intravascular…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now